PT  - JOURNAL ARTICLE
ED  - ,
TI  - ▾ Marvelon - an OC with a new progestagen
AID  - 10.1136/dtb.22.18.69
DP  - 1984 Sep 10
TA  - Drug and Therapeutics Bulletin
PG  - 69--70
VI  - 22
IP  - 18
4099  - http://dtb.bmj.com/content/22/18/69.short
4100  - http://dtb.bmj.com/content/22/18/69.full
SO  - Drug Ther Bull1984 Sep 10; 22
AB  - Marvelon (Organon) is a 21-day, fixed-dose combined oral contraceptive (OC) containing 30 mcg of ethinyloestradiol (EE) and 150 mcg of a new progestagen, desogestrel (D). It thus differs only by using D in place of the closely related levonorgestrel (LN) from the established formulation used in Microgynon 30 and Ovranette - which accounts for about one-third of the OC market in Britain.